Adenosine levels in the tumor microenvironment are several-fold higher than in healthy participants; therefore, the level of target engagement generated from a healthy participant study may be insufficient to maximize target engagement of both A2A and A2B receptors. Here, IGKV2D-29 is linked to neoplasm.